Commercial insight into the pharma and biotech sector.

Calendar of Events

  • First fully comprehensive online calendar to track events impacting shareholder value
  • Key events are prioritized by commercial impact - the forecast effect of the event on the Company's stock price
  • Events are linked to comment and analysis from EP VantageEP Vantage
  • Highlights potential event-based investment opportunities
  • Key events include:
    • Post-Marketing FDA Review
    • US Product Approval (PDUFA)
    • US Product Approval (PDUFA) (sNDA/sBLA)
    • EU Product Approval
    • US FDA Advisory Committee
    • Phase III Trial Results
    • Phase II Trial Results
    • US Patent Date Uncertain
    • US Generic Launch

Register for access to a selection of free analysis and insights